VU534
VU534 is a dual-action small molecule that acts as a NAPE-PLD agonist (EC50 = 0.30 μM) and inhibits both FAAH and soluble epoxide hydrolase (sEH IC50 = 1.2 μM) . Its modulation of lipid signaling pathways makes it a valuable research tool for in vitro and in vivo studies in cardiometabolic disease research.
Product Specifications
CAS Number
923509-20-0
Product Name Alternative
PLD, Epoxide Hydrolase, EpoxideHydrolase, FAAH, sEH, VU 534, VU534, VU-534
Field of Research
Metabolism Research, Neuroscience
Purity
98.85% (May vary between batches)
Solubility
DMSO:6.25 mg/mL (13.96 mM)
Smiles
CC1=CC2=C (SC (NC (=O) C3CCN (CC3) S (=O) (=O) C3=CC=C (F) C=C3) =N2) C (C) =C1
Molecular Formula
C21H22FN3O3S2
Molecular Weight
447.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC208849L4V 200 µL
TMCO4 (NM_181719) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
A12257-2-PE 100 µg/Vial
Anti-PHKG1 Antibody Picoband®, PE Conjugate
Sign In for Pricing
View Details 
E2202-50C-FITC 200 µL
EDD, CT (E3 Ubiquitin-protein Ligase UBR5, E3 Ubiquitin-protein Ligase, HECT Domain-containing 1, Hyperplastic Discs Protein Homolog, hHYD, Progestin-induced Protein, UBR5, EDD1, HYD, KIAA0896) (FITC) discontinued
Sign In for Pricing
View Details